HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis
暂无分享,去创建一个
M. Dalakas | E. Gerhardt | R. Voll | A. Wrede | S. Zierz | P. Balcarek | Olivia Schreiber-Katz | Jens Schmidt | J. Zschüntzsch | I. Muth | Konstanze Kleinschnitz | O. Schreiber-Katz
[1] V. Limaye,et al. Major Histocompatibility Complex Class I and II Expression in Idiopathic Inflammatory Myopathy , 2013, Applied immunohistochemistry & molecular morphology : AIMM.
[2] M. Dalakas,et al. Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives , 2013, Expert review of clinical immunology.
[3] J. Lünemann,et al. TNF-α upregulates macroautophagic processing of APP/β-amyloid in a human rhabdomyosarcoma cell line , 2013, Journal of the Neurological Sciences.
[4] H. Westerblad,et al. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis , 2012, Annals of the rheumatic diseases.
[5] W. Engel,et al. Pathogenic Considerations in Sporadic Inclusion-Body Myositis, a Degenerative Muscle Disease Associated With Aging and Abnormalities of Myoproteostasis , 2012, Journal of neuropathology and experimental neurology.
[6] J. Pei,et al. AGEs Induce Cell Death via Oxidative and Endoplasmic Reticulum Stresses in Both Human SH-SY5Y Neuroblastoma Cells and Rat Cortical Neurons , 2012, Cellular and Molecular Neurobiology.
[7] R. Gold,et al. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death. , 2012, Brain : a journal of neurology.
[8] U. Andersson,et al. HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease , 2012, Nature Reviews Rheumatology.
[9] Minhyung Lee,et al. Extracellular HMGB1 Released by NMDA Treatment Confers Neuronal Apoptosis via RAGE-p38 MAPK/ERK Signaling Pathway , 2011, Neurotoxicity Research.
[10] H. Westerblad,et al. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] Ho‐Youn Kim,et al. Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis , 2009, Clinical Rheumatology.
[12] B. De Paepe,et al. Role of cytokines and chemokines in idiopathic inflammatory myopathies , 2009, Current opinion in rheumatology.
[13] Stephan Saalfeld,et al. Globally optimal stitching of tiled 3D microscopic image acquisitions , 2009, Bioinform..
[14] M. Dalakas,et al. Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle , 2008, Brain : a journal of neurology.
[15] S. Houser,et al. Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes. , 2008, American journal of physiology. Heart and circulatory physiology.
[16] E. Abraham,et al. HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines1 , 2008, The Journal of Immunology.
[17] M. Haslbeck,et al. Factors masking HMGB1 in human serum and plasma , 2007, Journal of leukocyte biology.
[18] K. Tracey,et al. High mobility group box‐1 protein induces the migration and activation of human dendritic cells and acts as an alarmin , 2007, Journal of leukocyte biology.
[19] A. Maseri,et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] M. Dalakas,et al. Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies , 2006, Nature Clinical Practice Neurology.
[21] H. Wiendl,et al. Expression of toll‐like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL‐8 release, and up‐regulation of NKG2D‐ligands , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] E. Schleicher,et al. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy , 2005, Acta Neuropathologica.
[23] E. Hoffman,et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. , 2005, Arthritis and rheumatism.
[24] M. Dalakas,et al. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. , 2004, Brain : a journal of neurology.
[25] U. Andersson,et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. , 2004, Arthritis and rheumatism.
[26] K. Tracey,et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Hohlfeld,et al. Polymyositis and dermatomyositis , 2003, The Lancet.
[28] M. Dalakas,et al. Expression of IFN-γ-inducible chemokines in inclusion body myositis , 2003, Journal of Neuroimmunology.
[29] H. Harris,et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. , 2003, Arthritis and rheumatism.
[30] M. Bianchi,et al. The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.
[31] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[32] G. Schuler,et al. Induction of iNOS expression in skeletal muscle by IL-1β and NFκB activation: an in vitro and in vivo study , 2002 .
[33] K. Tracey,et al. High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.
[34] W. Engel,et al. Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation. , 2000, The American journal of pathology.
[35] Nagaraju,et al. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli , 1998, Clinical and experimental immunology.
[36] W. Tourtellotte,et al. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Chen,et al. The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.
[38] Heng Du,et al. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease. , 2012, Frontiers in bioscience.
[39] G. Borm,et al. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. , 2004, Journal of neurology, neurosurgery, and psychiatry.
[40] Hong Wang,et al. Structural Basis for the Proinflammatory Cytokine Activity of High Mobility Group Box 1 , 2003, Molecular medicine.